ArticleiMetaOmics2026
Oleoylethanolamide regulates intestinal stem cell activity and villus size via PPARα signaling pathway.
Article in iMetaOmics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The size of intestinal villi plays a critical role in determining digestive and absorptive functions, directly affecting nutrient digestibility and feed efficiency. Therefore, elucidating the key mechanisms regulating villus development is of significant importance. This study compares intestinal development in Shaziling pigs and Yorkshire pigs, which exhibit distinct lipid metabolism characteristics, revealing significant enrichment of different fatty acid metabolic pathways and the peroxisome proliferator-activated receptors (PPAR) signaling pathway. LC-MS metabolomics analysis further explores the potential correlation between changes in fatty acid metabolism and PPARα expression, identifying glycerophospholipid metabolism and its key metabolite oleoylethanolamide (OEA) as critical factors. Pharmacological interventions and genetic mouse models manipulating PPARα signaling demonstrate that OEA regulates stem cell activity and intestinal villus size via PPARα, with this effect linked to energy metabolism driven by oxidative phosphorylation. Notably, dietary supplementation with OEA or palmitoylethanolamide-another endogenous PPARα ligand increases villus size and nutrient digestibility. These findings indicate that lipid metabolism contributes to the regulation of intestinal villus size and uncover a novel mechanism by which N-acylethanolamines modulate intestinal morphological development through the PPARα-oxidative phosphorylation axis. The results provide a theoretical basis for developing novel feed additives based on endogenous lipid signaling molecules.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.